These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32129603)

  • 41. Glucose Oxidase Driven Hydrogen Sulfide-Releasing Nanocascade for Diabetic Infection Treatment.
    Ge Y; Rong F; Lu Y; Wang Z; Liu J; Xu F; Chen J; Li W; Wang Y
    Nano Lett; 2023 Jul; 23(14):6610-6618. PubMed ID: 37458704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucose- and pH-Responsive Supramolecular Polymer Vesicles Based on Host-Guest Interaction for Transcutaneous Delivery of Insulin.
    Lin Y; Hu W; Bai X; Ju Y; Cao C; Zou S; Tong Z; Cen C; Jiang G; Kong X
    ACS Appl Bio Mater; 2020 Sep; 3(9):6376-6383. PubMed ID: 35021768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitrilotriacetic Acid-Functionalized Glucose-Responsive Complex Micelles for the Efficient Encapsulation and Self-Regulated Release of Insulin.
    Li C; Huang F; Liu Y; Lv J; Wu G; Liu Y; Ma R; An Y; Shi L
    Langmuir; 2018 Oct; 34(40):12116-12125. PubMed ID: 30212220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucose-responsive complex micelles for self-regulated delivery of insulin with effective protection of insulin and enhanced hypoglycemic activity in vivo.
    Wu G; Li C; Liu X; Lv J; Ding Y; Liu Y; Liu Y; Huang F; Shi L; An Y; Ma R
    Colloids Surf B Biointerfaces; 2019 Aug; 180():376-383. PubMed ID: 31082775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo performance and biocompatibility of a subcutaneous implant for real-time glucose-responsive insulin delivery.
    Chu MK; Gordijo CR; Li J; Abbasi AZ; Giacca A; Plettenburg O; Wu XY
    Diabetes Technol Ther; 2015 Apr; 17(4):255-67. PubMed ID: 25671341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydrogen Peroxide-Triggered Conversion of Boronic Acid-Appended Insulin into Insulin and Its Application as a Glucose-Responsive Insulin Formulation.
    Kikuchi H; Nakamura Y; Inoue C; Nojiri S; Koita M; Kojima M; Koyama H; Miki R; Seki T; Egawa Y
    Mol Pharm; 2021 Nov; 18(11):4224-4230. PubMed ID: 34623822
    [No Abstract]   [Full Text] [Related]  

  • 47. Glucose-responsive nanoparticles designed via a molecular-docking-driven method for insulin delivery.
    Shen D; Yu H; Wang L; Feng J; Zhang Q; Pan J; Han Y; Ni Z; Liang R; Uddin MA
    J Control Release; 2022 Dec; 352():527-539. PubMed ID: 36341933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
    Chuang EY; Nguyen GT; Su FY; Lin KJ; Chen CT; Mi FL; Yen TC; Juang JH; Sung HW
    Biomaterials; 2013 Oct; 34(32):7994-8001. PubMed ID: 23891516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
    Kumar A; Lahiri SS; Singh H
    Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loading and release of fluorescent dye from layer-by-layer film-coated magnetic particles in response to hydrogen peroxide.
    Sato K; Abe E; Takahashi M; Anzai J
    J Colloid Interface Sci; 2014 Oct; 432():92-7. PubMed ID: 25084230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenylboronate-diol crosslinked glycopolymeric nanocarriers for insulin delivery at physiological pH.
    Guo Q; Wu Z; Zhang X; Sun L; Li C
    Soft Matter; 2014 Feb; 10(6):911-20. PubMed ID: 24835766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Star-shaped polyester-based elastomers as an implantable delivery system for insulin: Development, pharmacokinetics, pharmacodynamics, and biocompatibility.
    Guo F; Huang D; Zhang W; Yan Q; Yang Q; Yang Y; Li H; Yun J; Hong W; Yang G
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():180-187. PubMed ID: 29519427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenylboronic acid-based complex micelles with enhanced glucose-responsiveness at physiological pH by complexation with glycopolymer.
    Ma R; Yang H; Li Z; Liu G; Sun X; Liu X; An Y; Shi L
    Biomacromolecules; 2012 Oct; 13(10):3409-17. PubMed ID: 22957842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy.
    Ma Q; Bian L; Zhao X; Tian X; Yin H; Wang Y; Shi A; Wu J
    Mater Today Bio; 2022 Jan; 13():100181. PubMed ID: 34927045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New glucose oxidase-immobilized stimuli-responsive dextran nanoparticles for insulin delivery.
    Jamwal S; Ram B; Ranote S; Dharela R; Chauhan GS
    Int J Biol Macromol; 2019 Feb; 123():968-978. PubMed ID: 30448487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery.
    Volpatti LR; Matranga MA; Cortinas AB; Delcassian D; Daniel KB; Langer R; Anderson DG
    ACS Nano; 2020 Jan; 14(1):488-497. PubMed ID: 31765558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A bio-inspired injectable hydrogel as a cell platform for real-time glycaemic regulation.
    Zhang Y; Yang J; Zhang J; Li S; Zheng L; Zhang Y; Meng H; Zhang X; Wu Z
    J Mater Chem B; 2020 Jun; 8(21):4627-4641. PubMed ID: 32373901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats.
    Salvioni L; Fiandra L; Del Curto MD; Mazzucchelli S; Allevi R; Truffi M; Sorrentino L; Santini B; Cerea M; Palugan L; Corsi F; Colombo M
    Pharmacol Res; 2016 Aug; 110():122-130. PubMed ID: 27181095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Preparation of nanoparticles for sustained insulin release using poly (ethylene glycol) -poly (ε-caprolactone)-poly (N, N-diethylamino-2-ethylmethaerylate)].
    Wu L; Zhu WT; Wang J; Liu J; Zeng QB
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jul; 37(7):975-982. PubMed ID: 28736379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.